Our Mission

Sanova Tech was founded on a simple belief: access to healthcare should never depend on where someone lives, their background, what they earn, or how easily they can access care.

Today, millions of people face unnecessary barriers to treatment. Long travel distances, repeated hospital visits, financial constraints and limited access to specialised care often prevent patients from receiving the treatment they need, especially those in underserved communities.

We believe healthcare should adapt to patients, not the other way around.

In 2025, Sanova Tech was selected for the Stanford-led NATO DIANA Accelerator, helping shape the foundation of the company. Soon after, Matteo De Donatis joined as CTO, bringing extensive experience in on-body drug delivery systems and a successful exit in the field. Elias Bou Farhat later joined as CMO, contributing his Harvard Medical School PhD expertise in biomarkers and immunotherapy to strengthen our scientific foundation.

In the summer of 2026, we joined Cornell University's Hardware Prototyping Accelerator, where we developed our first functional prototype.

Today, we are working to make care more accessible, more personalised and ultimately better. By connecting treatment with meaningful insights, we aim to enable a future of more preventive and predictive care.

Because better healthcare begins with care that connects.